For over 60 years Novartis has been committed to helping people with cardiovascular disease and we remain steadfast in that commitment to this day.

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Researchers focus on reversing the scarring that’s common to liver diseases.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

Researchers discover that networks of proteins circulating in the blood influence the development and progression of chronic diseases.

A middle school student curious about science grows into a college-bound scientist.

Compound offers a potential tool for fighting drug-resistant malaria parasites.